Ngambenjawong C - Search Results

1

A Facile Cyclization Method Improves Peptide Serum Stability and Confers Intrinsic Fluorescence.

Ngambenjawong C, Gustafson HH, Sylvestre M, Pun SH. Ngambenjawong C, et al. Chembiochem. 2017 Dec 14;18(24):2395-2398. doi: 10.1002/cbic.201700446. Epub 2017 Nov 7. Chembiochem. 2017. PMID: 29044914 Free PMC article.

2

Serum Stability and Affinity Optimization of an M2 Macrophage-Targeting Peptide (M2pep).

Ngambenjawong C, Gustafson HH, Pineda JM, Kacherovsky NA, Cieslewicz M, Pun SH. Ngambenjawong C, et al. Theranostics. 2016 Jun 15;6(9):1403-14. doi: 10.7150/thno.15394. eCollection 2016. Theranostics. 2016. PMID: 27375788 Free PMC article.

3

Engineering an Affinity-Enhanced Peptide through Optimization of Cyclization Chemistry.

Ngambenjawong C, Pineda JM, Pun SH. Ngambenjawong C, et al. Bioconjug Chem. 2016 Dec 21;27(12):2854-2862. doi: 10.1021/acs.bioconjchem.6b00502. Epub 2016 Nov 10. Bioconjug Chem. 2016. PMID: 27779387 Free PMC article.

4

Reversibly Switchable, pH-Dependent Peptide Ligand Binding via 3,5-Diiodotyrosine Substitutions.

Ngambenjawong C, Sylvestre M, Gustafson HH, Pineda JMB, Pun SH. Ngambenjawong C, et al. ACS Chem Biol. 2018 Apr 20;13(4):995-1002. doi: 10.1021/acschembio.8b00171. Epub 2018 Mar 5. ACS Chem Biol. 2018. PMID: 29481044

5

Multivalent display of pendant pro-apoptotic peptides increases cytotoxic activity.

Chu DS, Bocek MJ, Shi J, Ta A, Ngambenjawong C, Rostomily RC, Pun SH. Chu DS, et al. Among authors: ngambenjawong c. J Control Release. 2015 May 10;205:155-61. doi: 10.1016/j.jconrel.2015.01.013. Epub 2015 Jan 14. J Control Release. 2015. PMID: 25596326 Free PMC article.

6

Synthesis and evaluation of multivalent M2pep peptides for targeting alternatively activated M2 macrophages.

Ngambenjawong C, Cieslewicz M, Schellinger JG, Pun SH. Ngambenjawong C, et al. J Control Release. 2016 Feb 28;224:103-111. doi: 10.1016/j.jconrel.2015.12.057. Epub 2016 Jan 7. J Control Release. 2016. PMID: 26772876 Free PMC article.

7

Progress in tumor-associated macrophage (TAM)-targeted therapeutics.

Ngambenjawong C, Gustafson HH, Pun SH. Ngambenjawong C, et al. Adv Drug Deliv Rev. 2017 May 15;114:206-221. doi: 10.1016/j.addr.2017.04.010. Epub 2017 Apr 25. Adv Drug Deliv Rev. 2017. PMID: 28449873 Free PMC article. Review.

8

Multivalent polymers displaying M2 macrophage-targeting peptides improve target binding avidity and serum stability.

Ngambenjawong C, Pun SH. Ngambenjawong C, et al. ACS Biomater Sci Eng. 2017 Sep 11;3(9):2050-2053. doi: 10.1021/acsbiomaterials.7b00332. Epub 2017 Jul 11. ACS Biomater Sci Eng. 2017. PMID: 29430522 Free PMC article.

9

Glomerular disease augments kidney accumulation of synthetic anionic polymers.

Liu GW, Prossnitz AN, Eng DG, Cheng Y, Subrahmanyam N, Pippin JW, Lamm RJ, Ngambenjawong C, Ghandehari H, Shankland SJ, Pun SH. Liu GW, et al. Among authors: ngambenjawong c. Biomaterials. 2018 Sep;178:317-325. doi: 10.1016/j.biomaterials.2018.06.001. Epub 2018 Jun 2. Biomaterials. 2018. PMID: 29891232

10

Conditional Antimicrobial Peptide Therapeutics.

Ngambenjawong C, Chan LW, Fleming HE, Bhatia SN. Ngambenjawong C, et al. ACS Nano. 2022 Oct 25;16(10):15779-15791. doi: 10.1021/acsnano.2c04162. Epub 2022 Aug 18. ACS Nano. 2022. PMID: 35980829 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12 results

Search Page

Filters